Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Pathology

• Publication date

  2011-08-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jclinpath-2011-200175PMID 21821860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia

  2011cited by this paper
• Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria

  2010cited by this paper
• A pilot study of the Histone‐Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms

  2010influential reference
• Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group

  2010cited by this paper
• Methylation of TET2, CBL and CEBPA in Ph-negative myeloproliferative neoplasms

  2010influential reference
• Methylation of cyclin-dependent kinase inhibitors, XAF1, JUNB, CDH13 and soluble Wnt inhibitors in essential thrombocythaemia

  2010cited by this paper
• Deactylase inhibition in myeloproliferative neoplasms

  2010cited by this paper
• High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms.

  2009cited by this paper
• Transcriptome Sequencing to Detect Gene Fusions in Cancer

  2009cited by this paper
• Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.

  2009cited by this paper
• Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues

  2009cited by this paper
• New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.

  2009cited by this paper
• Genome-wide DNA methylation profiling using Infinium® assay.

  2009cited by this paper
• A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms

  2009cited by this paper
• Hypermethylation of CXCR4 Promoter in CD34+ Cells from Patients with Primary Myelofibrosis

  2008cited by this paper
• Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases

  2008cited by this paper
• The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2V617F

  2008cited by this paper
• Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases

  2008cited by this paper
• Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders

  2008cited by this paper
• The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2(V617F).

  2008cited by this paper
• Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

  2007cited by this paper
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

  2005cited by this paper
• Une mutation unique de la protéine kinase JAK2 dans la polyglobulie de Vaquez et les syndromes myéloprolifératifs non-LMC

  2005cited by this paper

• DNA methylation and mRNA expression of ZNF577 as biomarkers for the detection and prognosis of lung adenocarcinoma.

  2024cites this paper
• Epigenomic insights into common human disease pathology

  2024cites this paper
• Epigenetics in myeloproliferative neoplasms

  2023cites this paper
• Methylation Profiling SOCS2 in Philadelphia-Negative Myeloproliferative Neoplasm

  2021cites this paper
• Molecular tumor classification using DNA methylome analysis.

  2020cites this paper
• Thrombocytémie essentielle

  2020cites this paper
• Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India

  2017cites this paper
• Obesity and menopause modify the epigenomic profile of breast cancer.

  2017cites this paper
• miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia

  2016cites this paper
• SOCS2: physiological and pathological functions.

  2016cites this paper
• Novel regional age-associated DNA methylation changes within human common disease-associated loci

  2016cites this paper
• Myeloproliferative neoplasms: Current molecular biology and genetics.

  2016cites this paper
• The Methylation Profile of IFN-γ, SOCS1 and SOCS3 Promoter Regions in End-Stage Renal Disease

  2013cites this paper
• CAPÍTULO 1 – Patogenia de las neoplasias mieloproliferativas

  2013cites this paper
• Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?

  2013cites this paper
• Methylation profiling of serum DNA from hepatocellular carcinoma patients using an Infinium Human Methylation 450 BeadChip

  2013cites this paper
• JAK2 Inhibition: Current Roles in Myelofibrosis and Initial Lessons Learned from Mexico

  2013cites this paper
• Cannabinoid Regulation of Serotonin 2A (5-HT 2A ) Receptor Signaling

  2013cites this paper
• Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm

  2013cites this paper
• JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms

  2013cites this paper
• Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms

  2013cites this paper
• Role of MXD3 in Proliferation of DAOY Human Medulloblastoma Cells

  2012cites this paper
• Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT2A and dopamine D2 receptors in rat prefrontal cortex

  2012influential citation
• JAK2 inhibitors in the treatment of myeloproliferative neoplasms

  2012cites this paper
• The clinical impact of DNA methylation frequencies of JAK2 negative regulators in patients with essential thrombocythemia.

  2012cites this paper
• A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies

  2012cites this paper